PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 75: Articles 37001-37500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Effect of sex hormones and intrauterine contraceptive suture on beta-glucuronidase activity of rat uterus.
  2. The effect of some oral contraceptive steroids on platelet electrophoretic mobility in vitro.
  3. Effect of some oral contraceptive steroids on the development of endometrial squamous metaplasia and cysts in rats.
  4. Effect of steroid contraceptives on lactation.
  5. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
  6. Effect of the intrauterine contraceptive device upon the biochemical composition of human endometrium.
  7. The effect of the oral contraceptive Ovosiston on the composition of human milk.
  8. The effect on hormone excretion patterns of depot medroxyprogesterone acetate used as a contraceptive preparation.
  9. Effectiveness evaluation of family planning: case study Taiwan.
  10. Effectiveness of the Majzlin spring intrauterine contraceptive device.
  11. The effects of a family planning advertising campaign on the sale of contraceptives.
  12. Effects of certain contraceptive hormones on blood coagulation.
  13. Effects of dietary vitamin B6 deficiency and oral contraceptives on the spontaneous urinary excretion of 3-hydreoxyanthranilic acid.
  14. Effects of hormonal contraceptives on hair growth in man. [Uber den Einfluss der hormonellen Kontrazeptiva auf das Haarwachstum des Menschen.]
  15. The effects of injectable contraceptives on lactation.
  16. The effects of injectable contraceptives on the direct thyroid function tests.
  17. Effects of medroxyprogesterone acetate employed as a long-term injectable contraceptive.
  18. Effects of oral contraceptive agents and sex steroids on carbohydrate metabolism.
  19. Effects of oral contraceptives on glycerides and sterol esters of human cervical mucus.
  20. Effects of oral contraceptives on lactation.
  21. Effects of oral contraceptives on phospholipids of human cervical mucus.
  22. Effects of some contraceptive hormones on blood coagulation. [Effets de certaines hormones contraceptives sur la coagulation du sang.]
  23. The effects of vitamin B6 on carbohydrate metabolism in women taking steroid contraceptives: preliminary report.
  24. Effects on contraceptive practices of a Scottish saturation project on family planning.
  25. Efforts, achievements and problems of Asian family planning programmes.
  26. El Salvador. (Family planning)
  27. Endocrinological studies in 2 patients with post contraceptive cyclic dysfunction.
  28. Eosinophil rhythms and oral contraceptives in rats.
  29. An epidemic model approach to the propagation of family planning ideas. (Abstract only)
  30. An epidemiologic justification for genetic counseling in family planning.
  31. The epidemiology of oral contraceptives in developing countries.
  32. Erythrocyte carbonic anhydrase B levels during pregnancy and use of oral contraceptives.
  33. Estimation of births averted by family planning programmes. (Objectives and approaches)
  34. Estrogenic activity in women receiving an injectable progestogen for contraception.
  35. Eugenics: its role in future family planning in Asia.
  36. Evaluating family planning programs in a Canadian context.
  37. Evaluation of a study in acceptance and continuation of oral contraceptives among women in a rural area.
  38. Evaluation of family planning program performance: a critical review.
  39. The evaluation of quingestanol acetate as a low dose oral contraceptive.
  40. Evaluation of the contraceptive efficacy of quingestanol acetate (W 4540) when administered as an oral low-dose contraceptive in the puerperium.
  41. Evaluation of the study on family planning services in urban Korea.
  42. Evaluation of the Venezuelan Family Planning Association's postpartum program. [Evaluacion del programa post-parto de la Asociacion Venezolana de Planificacion Familiar.]
  43. Evaluation report (interim) of the M.C.H. & family planning programme in Athoor - January 1972.
  44. Evaluation summary of family planning performance by main clinics.
  45. An examination for transferring the philosophical, methodological and operational aspects of a stateside family planning program to an overseas setting.
  46. Exhibits, displays: a unique selling tool for family planning.
  47. An experience in family planning in Nairobi.
  48. Experience of the birth control department. [Experiencia del departamento de regulacion de la natalidad.]
  49. Experience with newer types of intrauterine contraceptive suppositories of home-made origin. [Skusenosti s novsimi typmi intrauterinnych teliesok domaceho puvodu.]
  50. Experience with norgestrel-ethinyl oestradiol combination as oral contraceptive.
  51. Experience with the contraceptive effect of Depo-Provera, 300mg and 450 mg administered at 6 month intervals. [Zkusenosti s antikoncepcni ucinnosti Depo-Provery v davce 300mg a 450mg podanych v intervalech 6 mesicu.]
  52. Experience with the Dalkon Shield in a birth control program for teenagers.
  53. Experiences in dermatology with various contraceptives containing gestagen.
  54. Experiences of the Mission Hospitals in the post-partum approach to family planning.
  55. Experiences with a 3-monthly injection of medroxyprogesterone acetate (MPA) as a contraceptive agent. [Ervaringen met een 3-maanaelijkse injectie medroyxprogesteronacetaat (MPA) als contraceptivum.]
  56. Experimental vitamin B6 deficiency and the effect of oestrogen-containing oral contraceptives on tryptophan metabolism and vitamin B6 requirements.
  57. Expert group meeting to study the integrated use of folk media and mass media in Family Planning Communication Programmes, UNESCO/IPPF London, England, November 20-24, 1972.
  58. Experts meeting on integrated approach to the use of broadcasting and other communication media in family planning and development: Kuala-Lumpur (Malaysia) 14-18 August 1972.
  59. Experts meeting on the integrated use of folk media and mass media in family planning communication programmes, London, 20-24 November 1972.
  60. An exploratory study on barriers to family planning: race consciousness and fears of black genocide as a basis.
  61. Extension education in family planning.
  62. Factors related to knowledge, family size preference and practice of family planning in India.
  63. Facts and figures on family planning in South East Asia and Oceania region (IPPF)
  64. Family choice and procreative behavior of people attending family planning centers. [Options familiales et comportement procreateur de la clientele des centres de planning familial.]
  65. Family doctors and contraception. (Letter to the editor)
  66. Family interaction, family planning and fertility in the city of Durazno, Uruguay. (Abstract only)
  67. Family planning - birth control.
  68. Family planning - mass education.
  69. Family planning acceptors in Lagos, Nigeria.
  70. Family planning ads. (Letters to the editor)
  71. Family planning advocates will conduct major campaign to bring population report to public attention.
  72. Family planning and abortion.
  73. Family planning and abortion. (Letter to the editor)
  74. Family planning and abortion. (Letter to the editor)
  75. Family planning and abortion. (Letter to the editor)
  76. Family planning and cancer screening services as provided by paramedical personnel: a training program.
  77. Family planning and community health services.
  78. Family planning and conjugal roles: some further evidence.
  79. Family planning and demographic situation. Retrospective study in the community of Koprivnica. [O planiranju porodice i demografskoj situaciji. Osvrt na stanje u opcini Koprivnica.]
  80. Family planning and economic development in Africa.
  81. Family planning and health--an annotated bibliography.
  82. Family planning and maternal and child health in Chile.
  83. Family planning and medical responsibility.
  84. Family planning and population education programme in the developing countries and extension curriculum for the rural sector.
  85. Family planning and population growth in Korea: economic considerations.
  86. Family planning and population policy in Papua New Guinea.
  87. Family planning and Rotary Clubs.
  88. Family planning and the auxiliary.
  89. Family planning as part of total family health.
  90. The Family Planning Association of India's role in population education.
  91. Family Planning Association of India: report 1971-1972.
  92. Family planning at "Godrej."
  93. Family planning attitudes and motivation.
  94. Family planning by nurse-midwives: a significant concept in family planning program development.
  95. Family planning can cut infant mortality.
  96. A family planning clinic on campus: first year experience at the University of Hawaii.
  97. Family planning comes of age - ?
  98. Family planning communication: the daily newspaper.
  99. Family planning communication: the weekly magazine.
  100. Family planning computer gaming: the Quicktest Model.
  101. Family planning council of Nigeria: statistics of new cases only (birth control and sub-fertility) Jan to June 1972.
  102. Family planning during the first year after delivery by women in Kingston, Jamaica.
  103. Family planning education and motivation in an industrial set-up.
  104. Family planning evaluation: first quarter program achievement (January - March 1972)
  105. Family planning festival in Eastern U.P.
  106. Family planning for the home, working wives and mothers.
  107. A family planning glossary.
  108. Family planning goals and social work roles.
  109. Family planning goes to the people.
  110. Family planning in 19 rural counties.
  111. Family planning in a slum in Bombay.
  112. Family Planning in Africa.
  113. Family planning in Asia.
  114. Family planning in Britain. A local authority service in Bradford.
  115. Family planning in Britain. Studies on Current Health Problems No. 40.
  116. Family planning in charts 1967-1969. [Keluaraga berentjana dalam grafik 1967-1969.]
  117. Family planning in China. [Le planning familial en Chine.]
  118. Family planning in East Harlem.
  119. Family planning in Fiji 1972. Suva, Fiji,.
  120. Family planning in general practice.
  121. Family planning in health services.
  122. Family planning in Hong Kong.
  123. Family planning in hospitals: conference proceedings.
  124. Family planning in India. Programme information 1971-72.
  125. Family planning in India: a statewise analysis.
  126. Family planning in Iran: results of a survey and a mass media campaign.
  127. Family planning in Kenya 1973-77: a proposal for the training of family planning field educators and related personnel.
  128. Family planning in Kenya; program and problems.
  129. Family planning in Latin America: the past, present and future of IPPF.
  130. Family planning in North Carolina: the politics of a lukewarm issue.
  131. Family planning in Orissa; program information, 1972.
  132. Family planning in Thailand.
  133. Family planning in the area of maternal and infantile hygiene. [Le planning familial dans le cadre de l'hygiene maternelle et infantile.]
  134. Family planning in the N.H.S.
  135. Family planning in the People's Republic of China: report on first official IPPF visit.
  136. Family planning in the Philippines: an overview.
  137. Family planning in the Philippines: present status and current problems.
  138. Family planning in the Turkish press: a message and channel analysis and evaluation. Period: Dec. 23, 1971 - Jun. 23, 1972.
  139. Family planning in Tondo: housewives, husbands and clinics.
  140. Family planning information: do low-income families need and want it?
  141. Family planning official reports largest IUD study.
  142. Family planning payments. (Letter to the editor)
  143. Family planning performance in India.
  144. Family planning policy and administration; an overview.
  145. Family planning policy development in North Carolina: Weak Tea.
  146. Family planning practices of low income women in two communities.
  147. The family planning program in Korea: retrospect and prospects.
  148. Family planning programme administration: observations of some factors determining performance.
  149. The family planning programme in India.
  150. The family planning programme in Morocco.
  151. Family planning programme, Gujarat: fact book.
  152. Family planning programmes.
  153. Family planning programmes: prospects for conception control.
  154. Family planning programs in developing countries.
  155. Family planning programs in developing countries.
  156. Family planning programs in El Salvador. Background, description and projections. [Los programas de planificacion familiar en El Salvador. Antecendentes, descripcion y proyecciones.]
  157. Family planning programs in several African countries. [Programmy planirovaniya semi v nekotorykh stranakh afriki.]
  158. Family planning programs.
  159. Family planning programs: an economic approach.
  160. Family planning publicity through Radio Pakistan: an appraisal.
  161. Family planning service program plan: Seyhan Province, Turkey.
  162. Family planning service.
  163. Family planning services extended.
  164. Family planning services in Tennessee.
  165. Family planning services in the United States.
  166. The family planning specialist.
  167. Family planning the natural way: temperature and symptoms method.
  168. Family planning through an under-fives' clinic.
  169. Family planning training and services in Sweden.
  170. Family planning under socialism. [Planirovanie semi pri sotsializme.]
  171. Family planning, race consciousness, and the fear of race genocide.
  172. Family planning, yes] (Letter to the editor)
  173. Family planning, yes]...but.
  174. The family planning-nurse specialist: an evaluation.
  175. Family planning.
  176. Family planning. (Letter to the editor)
  177. Family planning: elements in the communication of an innovation.
  178. Family planning: new perspectives for human health and welfare.
  179. Family planning: the instrument for implementing population control.
  180. Family planning; postpartum approach.
  181. Family-planning and immunisation programs in developing countries [letter]
  182. FDA approves new oral contraceptive.
  183. Fecundity, fertility and family planning.
  184. Female undergraduate attitude toward distribution of the birth control pill on the campus.
  185. Femininity and Family Planning.
  186. Fertility patterns of the sterilised and contraceptive users in Kerala.
  187. Fertility, contraception and abortion in Italy.
  188. Fertility, knowledge, attitude and practice (KAP) study in relation to family planning in a selected population of the Armed Forces.
  189. Fibrinolytic activity of veins during use of depot medroxyprogesterone acetate as a contraceptive.
  190. Fibrinolytic activity: changes induced with oral contraceptives.
  191. A field study of family planning incentives and field staff in Indonesia.
  192. The first year of clinical experience with the copper T intrauterine contraceptive system in the United States and Canada.
  193. Five boroughs plan a comprehensive service. (Family planning)
  194. Folk media and mass media: their integrated use in communication programmes for social development and family planning.
  195. Follow-up survey of women under contraception. [Enquete de surveillance de femmes sous contraception.]
  196. For women, birth control via "Band-Aid surgery."
  197. Further experience with a once-a-month oral contraceptive: quinestrol-quingestanol.
  198. Future lines of research in the field of family planning.
  199. Gabon (Family planning)

     

  200. Gambia (Family planning)
  201. General practitioners and birth control advice in 1970/71.
  202. General practitioners and contraception in 1970-71.
  203. General practitioners and contraception. (England)
  204. Genetic effects of family planning.
  205. Genital yeast infections during treatment with oral contraceptives. [Genitale Hefemykosen unter Behandlung mit oralen Kontrazeptiva.]
  206. Girls under 18 can consent to birth control services in two-fifths of the states.
  207. Glasgow family planning service.
  208. The glucose-phosphate isomerase content of human cervical mucus of women using either steroid contraceptives, an intrauterine device, or no contraception.
  209. Govt. must participate in family planning.
  210. Grenada. (Family planning)
  211. Guyana (Family Planning)
  212. Gynecologic complications of contraception. [Complicazioni ginecologiche della contraccezione.]
  213. Harmful effects of common drugs on the visual apparatus. Hormones. 6. Oral contraceptives. [6. Contraceptifs oraux.]
  214. Health and family planning services in the Chinese People's Republic.
  215. Health aspects of family planning.
  216. The health visitor and family planning.
  217. Health visitors and birth control advice 1970/71 -- Part 1.
  218. Health visitors and birth control advice 1970/71--Part 2.
  219. Health, abortion, and contraception: Exclusively medical responsibilities and techniques. [Sante, avotement et contraception: Responsabilites et techniques exclusivement medicales.]
  220. Hindus and family planning.
  221. Historical review about contraception in Islam.
  222. History and role of the family planning nurse practitioner at Hartford Hospital.
  223. Hong Kong (Family planning)
  224. Hormonal balance of oral contraceptives: practical "pill" prescribing.
  225. Hormone-aided rhythm method valid as OCs for contraception.
  226. Hormones and contraception in the male-relative merits of hormonal control and vasectomy.
  227. How can family planning programs delay repeat teenage pregnancies?
  228. How dangerous are oral contraceptives?
  229. How soon will we have the "ideal" contraceptive?
  230. How states are using Title IV-A to finance family planning services.
  231. How to carry out a vasectomy program within the family planning programs in Latin America. [Como llevar a cabo un programa de vasectomias dentro de los servicios de planificacion familiar en America Latina.]
  232. The Hull family survey. II. Family planning in the first 5 years of marriage.
  233. Human reproduction and family planning: a programmed text.
  234. Husband's role in birth control acceptance.
  235. Husband-wife communication and fertility in a suburban community exposed to family planning.
  236. Husband-wife relations and family-planning practices in urban Hong Kong.
  237. Hydrocarbons in human cervical mucus and the effect of oral contraception.
  238. Hypertension and oral contraception.
  239. Hypothalamo-pituitary-adrenal function during oral contraceptive therapy with combined estrogen-progestogen and progestogen-only preparations.
  240. Hysteroscopy in connection with planned parenthood. [Hysteroskopie v suvise s planovanim rodicovstva.]
  241. Icterigenic liver disease due to pregnancy and oral contraceptives. Clinico-functional and histomorphological considerations. [Epatopatia itterigena da gravidanza e da contraccettivi orali. Consider azioni clinico-funzionali ed istomorfologiche.]
  242. Immediate postabortal intrauterine contraceptive device insertion: a double-blind study.
  243. An immunologic method of pregnancy destruction and contraception.
  244. Impact of social and economic factors on family planning-a case study.
  245. Impact of training and motivation on hospital staff in an integrated family planning program.
  246. The impediments to contraceptive usage: an overview.
  247. Implementation of family planning in the Republic of South Africa.
  248. The importance of family planning for pediatrics.
  249. The importance of K.A.P. studies in family planning programs.
  250. Importance of parental education and socioeconomic status in family planning and on immunization status of children.
  251. Improving administration in family planning.
  252. Improving the results obtained with current intrauterine contraceptive devices.
  253. Incentives in family planning programs: time for a new look.
  254. Incidence and pattern of contraceptive usage.
  255. Inconsistencies of attitudes and behavior in family-planning studies.
  256. Increasing consumer participation in professional goal setting: contraception and therapeutic abortion.
  257. Indications and limitations of the new contraceptive methods. [Indications et limites des nouvelles methodes contraceptives.]
  258. Indonesia (Family planning)
  259. The Indonesian National Family Planning Program: a cost-effectiveness analysis.
  260. Indonesian National Family Planning Service Statistics: a cost-effectiveness analysis.
  261. Indonesian National Family Planning Service statistics: the system and first year results.
  262. Industry and family planning-Tata family planning programme.
  263. Infiltrating duct carcinoma of the mammary gland of a rhesus monkey after administration of an oral contraceptive: a preliminary report.
  264. The influence of a combined oral contraceptive on the absorption of iron.
  265. Influence of contraception on psychology and sexual life. [Incidences de la contraception sur la psychologie et la vie sexuelle.]
  266. The influence of contraception on the haemostasis.
  267. The influence of education on the fertility of family planning acceptors in Barranquilla, Colombia.
  268. The influence of nibufine on the reproductive function and contraceptive effect of hormonal preparations. [Vliyanie nibufina na reproduktivnuyu funtsiyu i kontratseptivnyi effeky gormonalnykh preparatov.]
  269. Influence of steroid contraceptive agents, on glucose tolerance. [Vliv Steroidnich antikoncepcnich pripravku na glukosovou toleranci.]
  270. Information, education, and communication in the commercial marketing of contraceptives [preliminary draft]
  271. Institutional checks to family planning.
  272. Instructions for advising patients during treatment with hormonal contraceptives.
  273. Instrumentation problems in the psychological studies of family planning: a Nigerian experience.
  274. Integrated approach to family planning.
  275. The integration of family planning into general health care.
  276. Integration of family planning with general health care.
  277. Integration of nutrition and family planning services into African health care delivery system.
  278. The interaction of some oral contraceptive steroids with lipid monolayers and with erythrocytes.
  279. Interdisciplinary teaching of family planning.
  280. International aspects of family planning.
  281. The international family planning movement: aspects of its growth and development (1881-1971)
  282. Intra-uterine appliances in family planning.
  283. Intra-uterine contraception in nulligravidae. [Nitrodelozni antikoncepce u nuligravid.]
  284. Intracranial venous thrombosis complicating oral contraception.
  285. Intrauterine contraception using the copper-seven device.
  286. Intrauterine contraception with the copper-T device: effect upon endometrial morphology.
  287. Intrauterine contraception with the copper-T device: influence on endometrial acid and alkaline phosphatase, beta-glucuronidase and lactic dehydrogenase activities.
  288. Intrauterine contraception with the copper-T device: influence on protein and copper concentrations and enzyme activities in uterine washings.
  289. Intrauterine contraception with the DANA Super IUD. [Intrauterine Kontrazeption mit dem IUD DANA Super.]
  290. Intrauterine contraception.
  291. Intrauterine contraception.
  292. Intrauterine contraception. [La contracezione intrauterina.]
  293. Intrauterine contraception: a ten-year study.
  294. The intrauterine contraceptive device: a prospective 5-year clinical study.
  295. Intrauterine contraceptive devices: present status and future prospects.
  296. Intravenous glucose tolerance, insulin response, fasting blood glucose and serum insulin during short-term administration of a combined oral contraceptive.
  297. Introduction (to Part 2, Contraception)
  298. Introduction. (Family planning in Japan)
  299. Introduction. (Law, politics, and birth control.)
  300. Involvement of medical profession in family planning program of India.
  301. IPPF/UNESCO project on clearing house facilities for communications materials and equipment for family planning and population activities.
  302. The Iran family planning program.
  303. (Iran) Summary of contraceptive supplies.
  304. Irish ban on import of contraceptives challenged.
  305. Iron as a contraceptive? 1. In vitro immobilization of human spermatozoa with iron salts. [Eisen als Antikonzipiens? 1. In vitro-Immobilisierung menschlicher Spermien durch Eisensalze.]
  306. Iron as a contraceptive? 3. Local effects of vaginal iron chloride administration in rats and mice. [Eisen als Antikonzipiens? 3. Oertliche Auswirkungen der vaginalen Eisenchloridverabreichung bei Ratt und Maus.]
  307. Iron as a contraceptive? II. Contraceptive efficiency of vaginal treatment with iron chloride in female rats. [Eisen als Antikonzipiens? II. Kontrazeptive Wirksamkeit vaginaler Eisenc hloridbehandlung bei der Ratte.]
  308. Irreversible means of fertility control, a neglected family planning strategy.
  309. Irreversible renal failure secondary to hypertension induced by oral contraceptives.
  310. Is abortion a form of contraception?
  311. Is industry able to cope with research costs for new contraceptive agents?
  312. Is there family planning after birth?
  313. Islam, polygamy and family planning in Nigeria.
  314. Issues in family planning in relation to maternal and child health from a worldwide point of view.
  315. The IUD that's changing current thinking about contraceptives...Dalkon Shield.
  316. The IUD: intrauterine devices for contraception.
  317. Jamaica (Family planning)
  318. (Jamaica) Summary of contraceptive supplies.
  319. Japan (Family planning)
  320. Jaundice with Dubin-Johnson-Sprinz syndrome precipitated by oral contraceptives.
  321. Kanyakumari district accepts family planning.
  322. The Kenya National Family Planning Programme.
  323. Knowledge and attitude to family planning among the Kuvi-Kandha.
  324. Knowledge of family planning methods.
  325. Knowledge, attitude & practice (KAP) surveys in family planning: an overview of two decades of research.
  326. Knowledge, attitude and practice of family planning among nursing staff.
  327. Knowledge, practice and effectiveness of contraception in Belgium.
  328. Kymographic utero-tubal insufflation in investigating the mode of action of modern contraceptives.
  329. Laparoscopic sterilization in the family planning program in developing communities.
  330. Legal aspects of contraception in minors. [Rechtliche Aspekte der Antikonzeption bei Minderjahrigen.]
  331. Legal aspects of family planning in Indonesia.
  332. Legalized abortion and family planning.
  333. (Legislation relating to birth control.)
  334. Lesotho (Family planning)
  335. Lessons of Gujarat family planning campaign.
  336. Lipid metabolism in women ingesting gestagens as contraceptives. [Zdolnosci aromatyzacyjne lozyska ludzkiego perfundowanego in vitro - w zaleznosci od roznych warunkow doswiadczalnych.]
  337. Lipids and blood coagulation studies in women using steroidal hormones for contraception.
  338. Liver enzymes and cholestasis during the use of oral contraceptives. [Leberenzyme und Cholostase unter Ovulationshemmern.]
  339. Liver function tests in women using oral contraceptive.
  340. Liver studies during oral contraception with low doses of megestrol acetate.
  341. Liver vein thrombosis and ovulation inhibitors. Another case of Budd-Chiari syndrome after medication with oral contraceptive. [Lebervenenthrombose und Ovulationshemmer. Ein weiterer Fall von Budd-Chiari Syndrome nach Einnahme eines oralen Kontrazeptivums.]
  342. Lo de Nosotras: Pudor and family planning clinics in a Latin American city.
  343. Logical dimensions of survey research for family planning.
  344. Long term effects of oral contraception.
  345. Long term use of depot medroxy progesterone acetate as a contraceptive.
  346. Long-acting contraception: a brief report.
  347. Long-acting gestagen as a contraceptive agent. [Langverkande gestageninjektioner som preventivmedel.]
  348. Long-term studies of oral contraceptives and IUDs at the family planning centers of greater Los Angeles.
  349. The long-term use of injectable norethisterone enanthate as a contraceptive.
  350. Low-dose chlormadinone acetate for contraception.
  351. Low-income women seek best in contraception.
  352. Luteal suppression with D-norgestrel as a method of oral contraception: a report of practical experience.
  353. Luteinizing hormone-releasing hormone: new key to birth control?
  354. The male and family planning.
  355. Male contraception with a twist: tiny gold valves to control fertility.
  356. Male sexual behavior and use of contraceptives in Santiago, Chile.
  357. Male sterilisation: one form of birth control.
  358. Male youths' attitudes toward population control, family planning and desired family size.
  359. Mammary carcinogenesis in female and male mice receiving contraceptives or gestagens.
  360. Management and family planning programs: brief notes for other professionals.
  361. Management of family planning in India: a critique.
  362. Management of family planning: a plea for systems approach.
  363. Manpower and population planning in the Arab Republic of Egypt. Part 3: aspects of family planning: the Egyptian Family Planning Association.
  364. Manpower and population planning in the Arab Republic of Egypt. Part IV: Egypt's governmental program for family planning.
  365. Manpower utilization by subsidized family planning clinics: an economic criterion for determining the professional skill-mix.
  366. A manual for surveys of fertility and family planning: knowledge, attitudes, and practice.
  367. Marketing contraceptives by mail.
  368. Marriage applicants get birth control data.
  369. Mass communication experiment: a study in the promotion of family planning in Pakistan.
  370. Mass communication infrastructure, its use in population/family planning and the research basis for such use in 20 selected countries.
  371. Mass mailing manual for family planning: manual of procedures.
  372. Mass media for family planning communication.
  373. Mass vasectomy camps and incentives in Indian family planning.
  374. Mauritania (Family planning)
  375. Maximum acceptance study. (Excerpted from 1971 Year End Report, Taiwan Provincial Committee on Family Planning, Taichung, May 1972.)
  376. MCH and family planning services in an urban community perspectives in planning.
  377. MCH and family planning services in an urban community-perspectives in planning.
  378. MCH and family planning.

     

  379. Measures, policies and programmes affecting fertility, with particular reference to national family planning programmes.
  380. The mechanism of intravascular activation of the fibrinolytic system during hormonal contraception: a 3-month follow-up study.
  381. Medical advice on contraception. (Letter to Editor)
  382. Medical problems of family planning in West Bengal.
  383. Medical profession and family planning.
  384. Medroxyprogesterone acetate (MPA) for contraception.
  385. Medroxyprogesterone acetate as a contraceptive.
  386. Meeting of Experts on Research in Family Planning Communication, Davao City, Philippines, 24-28 October, 1972. Draft report.
  387. Megaloglastic anemia and oral contraceptives.
  388. Menstrual blood quantitation in the rhesus monkey: an experimental tool for improving intrauterine contraceptive devices (IUDs)
  389. Mental health and family planning.
  390. Mental retardation and family planning in Puerto Rico.
  391. Metabolic alterations associated with oral contraceptives.
  392. Metabolic effects of contraceptive steroids IV. Liver function tests--short term observations.
  393. Metabolic effects of contraceptive steroids. Pt. 2. Blood coagulation.
  394. Metabolic effects of contraceptive steroids. I. Observations of blood lipids.
  395. Metabolic effects of contraceptive steroids. III. Intravenous glucose tolerance--short term observations.
  396. Metabolic effects of oral contraceptives. [Stoffwechselwirkungen oraler contraceptiva.]
  397. The metabolism and effects of contraceptive steroids in primates.
  398. Metabolism of oral contraceptives: II. Metabolism of norethynodrel in women.
  399. Methods of birth control in the United States.
  400. Methods of contraception and their present day position.
  401. Methods of Contraception.
  402. Mexico. (Family planning)
  403. Middle cerebral artery occlusion from oral contraceptives? [Arteria-cerebri-media-Verschluss durch orale Kontrazeptiva?]
  404. Militant Hindu opposition to family planning in India.
  405. Mobile family planning.
  406. The mode of action of intrauterine contraceptive devices in laboratory animals.
  407. Model for a communication research project in family planning in a developing country.
  408. A model for determining information diffusion in a family planning program.
  409. The modernization of U.S. contraceptive practice.
  410. A modified sequential contraceptive.
  411. Monitoring adverse reactions to oral contraceptive agents.
  412. Montserrat. (Family planning)
  413. Morning after contraceptive triggers controversy.
  414. Motility of the oviduct in the rhesus monkey: in vivo studies with and without intrauterine contraceptive devices.
  415. Motivation and follow up in research in family planning clinics.
  416. Motivation and organization of family planning clinics.
  417. Motivation for the use of different contraceptive methods.
  418. Motivation of family planning in rural areas.
  419. Motivational and incentive components of the Korean family planning program. (Extract from larger paper.)
  420. Motivational factors associated with contraceptive usage: the case of limiters versus the spacers.
  421. Motivators in family planning.
  422. Multiple sclerosis and contraception.
  423. Muslim Women's Conference supports family planning.
  424. Myocardial infarct in young women - Is it related to oral contraceptives? [Hjartinfarkt hos yngre kvinnor - finns samband med p-piller?]
  425. Myocardial infarction and oral contraceptives. (Letter to the editor)
  426. The mythology of family planning programmes.
  427. National experiences with natural family planning: the Mauritius programme.
  428. National Family Planning Program of Korea (1962-1971)
  429. National Family planning program. [Programa nacional de planificacion familiar.]
  430. National Family Planning Programme.
  431. National family planning programs: review and evaluation.
  432. Natural family planning.
  433. The need for a family planning programme in Dominica, West Indies.
  434. The need for family planning information activities: a conceptual model.
  435. Need for subsidized family planning services: United States, each state and county, 1969.
  436. Neurological complications in women using oral contraceptives. [Powiklania neurologiczne u kobiet stosujacych doustne srodiki antykoncepcyjne.]
  437. A new circumstance in the appearance of the amenorrhea-galactorrhea syndrome: hormone therapy administered for contraceptive purposes. [Une nouvelle circonstance d'apparition du syndrome amenorrhee-galactorrhee; l'hormonotherapie administree dans un but anticonceptionnel.]
  438. New concepts in contraception.
  439. The new Cu-7 birth control device.
  440. New findings associated with the development and use of hormonal contraception. [Neuere Ergebnisse bei der Entwicklung und Anwendung der hormonalen Kontrazeption.]
  441. New method for administration of low-dose gestagen as a contraceptive: megestrol acetate 0.350 mg twice daily.
  442. New prospects in the field of contraception. [Nuove prospettive nel campo della contraccezione.]
  443. New regulations govern family planning grants.
  444. New technique of reversible operation for family planning programme of female.
  445. New York State survey on "morning after" estrogen contraceptive therapy.
  446. Oral contraceptives and antithrombin-3 activity: a new method of antithrombin estimation. (Abstract only)
  447. Oral contraceptives and breast neoplasia: a retrospective study.
  448. Oral contraceptives and cancer.
  449. Oral contraceptives and cancer. (Letter to the editor)
  450. Oral contraceptives and carbohydrate metabolism.
  451. Oral contraceptives and cholestasis. [Ovulationshemmer und Cholestase.]
  452. Oral contraceptives and correlation between serum copper and ceruloplasmin levels.
  453. Oral contraceptives and erythema nodosum.
  454. Oral contraceptives and genetics.
  455. Oral contraceptives and hypertension--an epidemiological survey.
  456. Oral contraceptives and hypertension. (Abstract only)
  457. Oral contraceptives and hypertension: an experimental model. (Abstract only)
  458. Oral contraceptives and in vivo cytogenetic studies.
  459. Oral contraceptives and NBT test. (Letter to the editor)
  460. Oral contraceptives and plasma lipids.
  461. Oral contraceptives and platelet function.
  462. Oral contraceptives and prevention of cancer of the uterus and breast.
  463. Oral contraceptives and serum amylase. (Letter to the editor)
  464. Oral contraceptives and serum amylase. (Letter to the editor)
  465. Oral contraceptives and serum amylase. (Letter to the editor)
  466. Oral contraceptives and the liver.
  467. Oral contraceptives and thrombo-embolic disease. (Letter to the editor)
  468. Oral contraceptives and thrombo-embolism.
  469. Oral contraceptives and thromboembolic disease [letter]
  470. Oral contraceptives and thromboembolic disease. (Letter to the editor)
  471. Oral contraceptives and thromboembolic disease. (Letter to the editor)
  472. Oral contraceptives and thromboembolic disease. II. Estrogen content or oral contraceptives.
  473. Oral contraceptives and thromboembolic disease: prospective and retrospective studies.
  474. Oral contraceptives and thromboembolism.
  475. Oral contraceptives and thrombogenesis. [Contraceptifs oraux et thrombogenese.]
  476. Oral contraceptives and trace metals.
  477. Oral contraceptives and triglyceride transport: acquired heparin resistance as the mechanism for impaired post-heparin lipolytic activity.
  478. Oral contraceptives and trytophan metabolism: effects of oestrogen in low dose combined with a progestagen and of a low-dose progestagen (megestrol acetate) given alone.
  479. Oral contraceptives and venous disorders. [Orale Kontrazeptiva und Venenerkrankungen.]
  480. Oral contraceptives containing only progestogens.
  481. Oral contraceptives contraindicated for nursing mother.
  482. oral contraceptives in patients with heart trouble. [Orale Kontrazeption bei Herzpatientinnen.]
  483. Oral contraceptives programme to test how advertising could improve attitudes and usage in the U.K.
  484. Oral contraceptives, depression, and sexual adjustment. (Letter to the editor)
  485. Oral contraceptives, depression, sexual adjustment, and fear of pregnancy. (Letter to the editor)
  486. Oral contraceptives, norethynodrel and mestranol: effects on glucose tolerance, tissue uptake of glucose-U-carbon-14 and insulin sensitivity.
  487. Oral contraceptives, pregnancy, and blood pressure.
  488. Oral contraceptives, thrombosis, and cigarette smoking. [P-piller, trombose, og sigarettroking.]
  489. Oral contraceptives. Reevaluation of the caution statement. [P-piller: Revurdering av advarselstekst.]
  490. Oral contraceptives: the Indonesian experience.
  491. Organization for change: origins of the birth-control movement.
  492. Otosclerosis and hormonal contraception. [Otosklerose und hormonale Kontrazeption.]
  493. Our experience with chemical contraceptives. [Nase skusenosti s chemickou antikoncepciou.]
  494. Our experiences with the use of the Depo-Provera contraceptive preparation. [Nase skusenosti s pouzitim antikoncepcneho prostriedku Depo-Provera.]
  495. Our opinion on the planned parenthood clinic. [Nas nahlad na poradna planovaneho rodicovstva.]
  496. Outline of evaluation-research activities for Korea's national family planning program: achievements and problems.
  497. Ovarian morphology after prolonged use of steroid contraceptive agents.
  498. Ovarian sensitivity to human gonadotrophins in women with amenorrhoea after oral contraceptive treatment.
  499. An overall analysis of the results of government family planning research activities.
  500. Overcoming resistance to family planning.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.